Within the program which runs from 2014 to 2018 and will be publicly funded by about 10 billion Yen (~ 70 million €), it will be attempted to combine knowledge on micro RNA tumor markers from several 100.000 patients stored in BioBank, and the highly sensitive DNA chip which Toray has developed, to build a database for the expression status of micro-RNA in body fluids which can be used in early detection of dementia, Alzheimer disease and 13 kinds of cancer, such as colon and breast cancer.

NEDO news release, August 18, 2014